Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Inventory (2018 - 2026)

TELA Bio has reported Inventory over the past 8 years, most recently at $11.0 million for Q4 2025.

  • For Q4 2025, Inventory fell 13.81% year-over-year to $11.0 million; the TTM value through Dec 2025 reached $11.0 million, down 13.81%, while the annual FY2025 figure was $11.0 million, 13.81% down from the prior year.
  • Inventory for Q4 2025 was $11.0 million at TELA Bio, down from $11.6 million in the prior quarter.
  • Over five years, Inventory peaked at $15.1 million in Q1 2023 and troughed at $4.5 million in Q2 2021.
  • A 5-year average of $11.3 million and a median of $12.0 million in 2022 define the central range for Inventory.
  • Biggest five-year swings in Inventory: skyrocketed 128.54% in 2022 and later fell 15.01% in 2025.
  • Year by year, Inventory stood at $7.7 million in 2021, then surged by 53.98% to $11.8 million in 2022, then rose by 11.62% to $13.2 million in 2023, then fell by 2.89% to $12.8 million in 2024, then fell by 13.81% to $11.0 million in 2025.
  • Business Quant data shows Inventory for TELA at $11.0 million in Q4 2025, $11.6 million in Q3 2025, and $11.4 million in Q2 2025.